poisar

Stocks · News reference

ACTO Integrates AI Roleplay Solution with Veeva Vault CRM

Fiscal.ai

ACTO Technologies has launched its AI-driven roleplay solution, CxZone, within Veeva Vault CRM via X-Pages to assist life sciences field teams.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchZacks.Com

    Vivos Therapeutics, Inc. (VVOS) Reports Q3 Loss, Beats Revenue Estimates

    Vivos Therapeutics reported a Q3 loss of $0.07 per share, beating consensus estimates of $0.30 loss by 76.67%. Revenue came in at $6.41 million, surpassing estimates by 17.15%, though down from $6.78 million year-ago. The stock has declined 95.2% year-to-date and carries a Zacks Rank #3 (Hold) rating with mixed estimate revisions.

  2. Globenewswire IncNot Specified

    Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management

    Devia, an agentic AI platform spun out from Visium, officially launched to help biopharma companies, CDMOs, and CROs manage pharmaceutical deviations. The platform automates deviation investigation workflows from initial report through root cause analysis and CAPA, with built-in traceability for regulatory compliance. After a year of pilot testing with quality teams, Devia claims to have halved investigation time while integrating with existing validated systems like TrackWise and Veeva Vault QMS.